Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency

被引:19
|
作者
Chinwong, Dujrudee [1 ,2 ]
Patumanond, Jayanton [3 ]
Chinwong, Surarong [1 ]
Siriwattana, Khanchai [4 ]
Gunaparn, Siriluck [5 ]
Hall, John Joseph [6 ]
Phrommintikul, Arintaya [5 ]
机构
[1] Chiang Mai Univ, Fac Med, Dept Pharmaceut Care, Chiang Mai 50200, Thailand
[2] Chiang Mai Univ, Fac Med, Clin Epidemiol Program, Chiang Mai 50200, Thailand
[3] Thammasat Univ, Fac Med, Ctr Excellence Appl Epidemiol, Pathum Thani, Thailand
[4] Nakornping Hosp, Div Med, Chiang Mai, Thailand
[5] Chiang Mai Univ, Fac Med, Dept Internal Med, Chiang Mai 50200, Thailand
[6] Univ Newcastle, Fac Hlth, Sch Med & Publ Hlth, Ctr Clin Epidemiol & Biostat, Callaghan, NSW 2308, Australia
关键词
LDL-C goal attainment; statins; potency statins; high risk; propensity score; LIPID-LOWERING TREATMENT; HIGH-RISK; HYPERCHOLESTEROLEMIC PATIENTS; LDL-C; MEDICATION ADHERENCE; CLINICAL-PRACTICE; PROPENSITY SCORE; ACHIEVEMENT; SIMVASTATIN; EZETIMIBE;
D O I
10.2147/TCRM.S75608
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Elevated low-density lipoprotein cholesterol (LDL-C) is associated with an increased risk of coronary artery disease. Current guidelines recommend an LDL-C target of <70 mg/dL (<1.8 mmol/L) for acute coronary syndrome (ACS) patients, and the first-line treatment to lower lipids is statin therapy. Despite current guidelines and the efficacious lipid-lowering agents available, about half of patients at very high risk, including ACS patients, fail to achieve their LDL-C goal. This study assessed LDL-C goal attainment according to use of high and low potency statins in routine practice in Thailand. Methods: A retrospective cohort study was performed by retrieving data from medical records and the electronic hospital database for a tertiary care hospital in Thailand between 2009 and 2011. Included were ACS patients treated with statins at baseline and with follow-up of LDL-C levels. Patients were divided into high or low potency statin users, and the proportion reaching the LDL-C goal of. 70 mg/dL was determined. A Cox proportional hazard model was applied to determine the relationship between statin potency and LDL-C goal attainment. Propensity score adjustment was used to control for confounding by indication. Results: Of 396 ACS patients (60% males, mean age 64.3 +/- 11.6 years), 229 (58%) were treated with high potency statins and 167 (42%) with low potency statins. A quarter reached their target LDL-C goal (25% for patients on high potency statins and 23% on low potency statins). High potency statins were not associated with increased LDL-C goal attainment (adjusted hazards ratio 1.22, 95% confidence interval 0.79-1.88; P=0.363). Conclusion: There was no significant effect of high potency statins on LDL-C goal attainment. Moreover, this study showed low LDL-C goal attainment for patients on either low or high potency statins. The reasons for the low LDL-C goal attainment rate warrants further investigation.
引用
收藏
页码:127 / 136
页数:10
相关论文
共 50 条
  • [21] Attainment of low-density lipoprotein cholesterol goals in patients treated with combination therapy: A retrospective cohort study in primary care
    Marquina, Clara
    Talic, Stella
    Zomer, Ella
    Vargas-Torres, Sandra
    Petrova, Marjana
    Wolfe, Rory
    Abushanab, Dina
    Lybrand, Sean
    Thomson, David
    Stratton, Giles
    Ofori-Asenso, Richard
    Liew, Danny
    Ademi, Zanfina
    JOURNAL OF CLINICAL LIPIDOLOGY, 2022, 16 (04) : 498 - 507
  • [22] Use of health information technology (HIT) to improve statin adherence and low-density lipoprotein cholesterol goal attainment in high-risk patients: Proceedings from a workshop
    Cohen, Jerome D.
    Aspry, Karen E.
    Brown, Alan S.
    Foody, JoAnne M.
    Furman, Roy
    Jacobson, Terry A.
    Karalis, Dean G.
    Kris-Etherton, Penny M.
    LaForge, Ralph
    O'Toole, Michael F.
    Scott, Ronald D.
    Underberg, James A.
    Valuck, Thomas B.
    Willard, Kaye-Eileen
    Ziajka, Paul E.
    Ito, Matthew K.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2013, 7 (06) : 573 - 609
  • [23] Statin Dosing Instructions, Medication Adherence, and Low-Density Lipoprotein Cholesterol: a Cohort Study of Incident Statin Users
    Zachary A. Marcum
    Hsiao-Ching Huang
    Robert J. Romanelli
    Journal of General Internal Medicine, 2019, 34 : 2559 - 2566
  • [24] Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients The GAUSS Randomized Trial
    Sullivan, David
    Olsson, Anders G.
    Scott, Rob
    Kim, Jae B.
    Xue, Allen
    Gebski, Val
    Wasserman, Scott M.
    Stein, Evan A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (23): : 2497 - 2506
  • [25] Low-density lipoprotein cholesterol goal attainment in high-risk family medicine patients
    Griend, Joseph P. Vande
    Saseen, Joseph J.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2009, 3 (03) : 195 - 200
  • [26] Attainment of low-density lipoprotein cholesterol goals in coronary artery disease
    Kauffman, Amy B.
    Olson, Kari L.
    Youngblood, Morgan L.
    Zadvorny, Emily B.
    Delate, Thomas
    Merenich, John A.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2010, 4 (03) : 173 - 180
  • [27] A VOYAGER Meta-Analysis of the Impact of Statin Therapy on Low-Density Lipoprotein Cholesterol and Triglyceride Levels in Patients With Hypertriglyceridemia
    Karlson, Bjorn W.
    Palmer, Michael K.
    Nicholls, Stephen J.
    Lundman, Pia
    Barter, Philip J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (09) : 1444 - 1448
  • [28] Baseline Low-Density Lipoprotein Cholesterol and Clinical Outcomes of Combining Ezetimibe With Statin Therapy in IMPROVE-IT
    Oyama, Kazuma
    Giugliano, Robert P.
    Blazing, Michael A.
    Park, Jeong-Gun
    Tershakovec, Andrew M.
    Sabatine, Marc S.
    Cannon, Christopher P.
    Braunwald, Eugene
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (15) : 1499 - 1507
  • [29] Rooted in risk: genetic predisposition for low-density lipoprotein cholesterol level associates with diminished low-density lipoprotein cholesterol response to statin treatment
    Smit, Roelof A. J.
    Postmus, Iris
    Trompet, Stella
    Barnes, Michael R.
    Warren, Helen
    Arsenault, Benoit J.
    Chasman, Daniel I.
    Cupples, L. Adrienne
    Hitman, Graham A.
    Krauss, Ronald M.
    Li, Xiaohui
    Psaty, Bruce M.
    Stein, Charles M.
    Rotter, Jerome I.
    Jukema, J. Wouter
    PHARMACOGENOMICS, 2016, 17 (15) : 1621 - 1628
  • [30] Low-density lipoprotein cholesterol goal attainment in Germany: Results from the DA VINCI study
    Gouni-Berthold, Ioanna
    Schaper, Frank
    Schatz, Ulrike
    Tabbert-Zitzler, Anja
    Fraass, Uwe
    Sauer, Sarah
    Ray, Kausik K.
    ATHEROSCLEROSIS PLUS, 2022, 50 : 10 - 16